David Apelian - Net Worth and Insider Trading
David Apelian Net Worth
The estimated net worth of David Apelian is at least $3,120 dollars as of 2024-11-13. David Apelian is the Director of Eiger BioPharmaceuticals Inc and owns about 367 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $3,120. David Apelian is also the Chief Medical Officer of Achillion Pharmaceuticals Inc and owns about 0 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $0. Details can be seen in David Apelian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Apelian has not made any transactions after 2022-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Apelian
David Apelian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Apelian owns 2 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) , and Achillion Pharmaceuticals Inc (ACHN) .
Click here to see the complete history of David Apelian’s form 4 insider trades.
Insider Ownership Summary of David Apelian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-08-16 | director |
| ACHN | Achillion Pharmaceuticals Inc | 2017-01-17 | Chief Medical Officer |
David Apelian Latest Holdings Summary
David Apelian currently owns a total of 2 stocks. Among these stocks, David Apelian owns 367 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of August 16, 2022, with a value of $3,120 and a weighting of 100%. David Apelian also owns 0 shares of Achillion Pharmaceuticals Inc (ACHN) as of December 30, 2015, with a value of $0 and a weighting of 0%.
Latest Holdings of David Apelian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-08-16 | 367 | 8.50 | 3,120 |
| ACHN | Achillion Pharmaceuticals Inc | 2015-12-30 | 0 | 6.76 | 0 |
Holding Weightings of David Apelian
David Apelian Form 4 Trading Tracker
According to the SEC Form 4 filings, David Apelian has made a total of 1 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Eiger BioPharmaceuticals Inc is the sale of 167 shares on August 16, 2022, which brought David Apelian around $49,050.
According to the SEC Form 4 filings, David Apelian has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 10,000 shares on December 30, 2015, which brought David Apelian around $105,000.
Insider Trading History of David Apelian
- 1
David Apelian Trading Performance
David Apelian Ownership Network
Ownership Network List of David Apelian
Ownership Network Relation of David Apelian
David Apelian Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
David Apelian is the director of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, David Apelian made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 10,086 shares were bought by its insiders, resulting in a net purchase of 10,086 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
David Apelian Mailing Address
Above is the net worth, insider trading, and ownership report for David Apelian. You might contact David Apelian via mailing address: C/o Achillion Pharmaceuticals, Inc, 300 George Street, New Haven Ct 06511.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
